FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10372122
United States Court of Appeals for the Ninth Circuit

Robert Leclair v. James Dzurenda

No. 10372122 · Decided April 3, 2025
No. 10372122 · Ninth Circuit · 2025 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
April 3, 2025
Citation
No. 10372122
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 3 2025 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT ROBERT LECLAIR, No. 23-15334 Plaintiff-Appellee, D.C. No. 3:19-cv-00404-MMD-CLB v. JAMES DZURENDA; et al., MEMORANDUM* Defendants-Appellants, and CHARLES DANIELS; HAROLD WICKHAM, Defendants. Appeal from the United States District Court for the District of Nevada Miranda M. Du, Chief District Judge, Presiding Submitted April 1, 2025** San Francisco, California Before: HURWITZ, KOH, and JOHNSTONE, Circuit Judges. * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). Robert LeClair, a Nevada state prisoner, claims in this 42 U.S.C. § 1983 action that Nevada Department of Corrections (“NDOC”) employees (collectively “Defendants”) violated the Eighth Amendment by denying him Hepatitis C (“Hep- C”) treatment pursuant to NDOC Medical Directive 219 (“MD 219”). The district court denied the Defendants’ motion for summary judgment, finding that they were not entitled to qualified immunity. Exercising jurisdiction over the appeal of the denial of summary judgment under 28 U.S.C. § 1291 and the collateral order doctrine, see Andrews v. City of Henderson, 35 F.4th 710, 715 (9th Cir. 2022), and reviewing de novo, see Carley v. Aranas, 103 F.4th 653, 659 (9th Cir. 2024), we reverse and remand. “Prison officials violate the Eighth Amendment if they are deliberately indifferent to a prisoner’s serious medical needs.” Peralta v. Dillard, 744 F.3d 1076, 1081 (9th Cir. 2014) (en banc) (cleaned up). “Section 1983 . . . provides a cause of action in tort” for such violations. Carley, 103 F.4th at 659. Prison officials, however, may assert qualified immunity as a defense in a § 1983 deliberate indifference suit. See, e.g., id. at 659. Determining whether the officials are entitled to qualified immunity potentially involves “two questions: (1) whether the official’s conduct violated a constitutional right; and (2) whether that right was clearly established at the time of the violation.” Id. at 659 (cleaned up). But if the answer to the second question is “no,” officials are protected by qualified immunity even if 2 there is a constitutional violation. See id. “For a right to be clearly established, it must be ‘sufficiently clear that every reasonable official would have understood that what he is doing violates that right.’” Id. at 660 (quoting Rivas-Villegas v. Cortesluna, 595 U.S. 1, 5 (20221) (per curiam)). We have discretion to determine the order in which these inquiries are addressed. See Pearson v. Callahan, 555 U.S. 223, 236 (2009). LeClair claims that Defendants “acted with deliberate indifference to” his “serious medical needs by developing and implementing MD 219.” The Defendants are therefore entitled to qualified immunity unless it was clearly established between 2012 and November 2019, the period during which LeClair was denied Hep-C treatment, that MD-219 violated the Eighth Amendment.1 We recently held that it was not clearly established by May 2018 that denying a Nevada state prisoner Hep-C treatment under MD 219 constituted deliberate indifference. See Carley, 103 F.4th at 661-62. LeClair does not contend that the law became clearly established to the contrary between May 2018 and November 2019. Because “no decision of the Supreme Court, our court, or a consensus of courts 1 Under a September 2019 revision to MD 219, LeClair became eligible for treatment, which he began in November 2019. In October 2020, NDOC entered into a consent decree providing that all prisoners testing positive for Hep-C will receive treatment. See In re HCV Prison Litig., No. 19-cv-00577, 2020 WL 6363842 (D. Nev. Oct. 29, 2020). 3 would have put [the Defendants] on notice that treatment prioritization schemes like MD 219 violated the Eighth Amendment” during the relevant period, id. at 662-63 (cleaned up), the Defendants were entitled to qualified immunity, even assuming that MD 219 is unconstitutional. The district court therefore should have granted the Defendants’ motion for summary judgment. We reverse its order denying summary judgment and remand with instructions to grant the Defendants’ motion. REVERSED AND REMANDED.2 2 Defendants’ request for judicial notice, Dkt. 24, is granted. 4
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 3 2025 MOLLY C.
Key Points
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 3 2025 MOLLY C.
FlawCheck shows no negative treatment for Robert Leclair v. James Dzurenda in the current circuit citation data.
This case was decided on April 3, 2025.
Use the citation No. 10372122 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →